Inherited Cancer Registry (ICARE)
ICARE Social Media Post April 2020PALB2: Cancer Risks and Risk Management
ICARE Social Media Post May 2020New Blood Test May Find Ovarian Cancer Early
On April 29, 2020 the FDA approved the use of niraparib (Zeluja) as first-line maintenance treatment in BRCA1/2 carriers with advanced ovarian cancer!
More details available at: https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-niraparib-first-line-maintenance-advanced-ovarian-cancer
Permanent link to this article: https://inheritedcancer.net/post42920/
Made with by Graphene Themes.